The Track III is providing you more comprehensive coverage and case studies in all areas of drug discovery. It offers you an insight into the novel developments in the drug discovery, and to analyse the future of these sectors within the drug development process.

Session 9: Part I: Peptide / Protein as Anti-Cancer Agents

Speaking Opportunities Available

This session will include the following peptide/protein drug discovery on the following cancers:

• Skin cancer
• Lung cancer
• Colon cancer
• Rectal cancer
• Breast cancer
• Endometrial cancer
• Ovarian cancer
• Prostate cancer
• Carcinoma
• Sarcoma
• Myeloma
• Melanoma
• Leukemia
• Lymphoma
• Adenosquamous carcinoma
• mixed mesodermal tumor
• carcinosarcoma
• teratocarcinoma

  Or you can propose new topics to be covered from your expert opinion here!

Session 10: From CADD to Booming Peptide Drug Development

Speaking Opportunities Available

This session will cover the following areas:

• Ligand-Based and Structure-Based Drug Design
• QSAR and 3D-QSAR Methods
• Pharmacophore Perception and Case Studies
• 3D Databases and 3D Searching
• Combinatorial Chemistry and Chemical Diversity Concepts
• Computer-Assisted Drug Design: Concepts, Methods, and Practical Approaches
• Protein/Peptide Design
• Structure based analysis of small molecule drugs

  Or you can propose new topics to be covered from your expert opinion here!

Session 11: Part II: Peptide / Protein as Anti-Cancer Agents

Speaking Opportunities Available

This session will include the following peptide/protein drug discovery on the following cancers:

• Skin cancer
• Lung cancer
• Colon cancer
• Rectal cancer
• Breast cancer
• Endometrial cancer
• Ovarian cancer
• Prostate cancer
• Carcinoma
• Sarcoma
• Myeloma
• Melanoma
• Leukemia
• Lymphoma
• Adenosquamous carcinoma
• mixed mesodermal tumor
• carcinosarcoma
• teratocarcinoma

  Or you can propose new topics to be covered from your expert opinion here!

Session 12: Peptide / Protein as Anti-Infective Drugs

Speaking Opportunities Available

This session covers the following topics on protein and peptide drug discovery:

Anti-Virus Protein and Peptides

• HIV and AIDS
• Demographics and Epidemiology
• Cytomegalovirus
• Hepatitis B Virus
• Hepatitis C Virus (HCV)
• Herpes
• Human Immunodeficiency Virus (HIV)
• Human Papillomavirus (HPV)
• Influenza
• Respiratory Syncytial Virus (RSV)
• Population Demographics

Anti-Fungal Protein and Peptides

• Superficial
• Systemic
• Histoplasmosis
• Coccidioidomycosis
• Blastomycosis

Anti-bacterial Protein and Peptides

• complicated skin and skin structure infections (cSSSI),
• gram+ and gram- infections,
• prevention of catheter-related infections,
• otitis media,
• gingivitis
• hemocidins,
• broad-spectrum antibacterial peptides
• Other New Promising Findings

  Or you can propose new topics to be covered from your expert opinion here!

Session 13: Proteins/Peptides for CNS Diseases

Speaking Opportunities Available

This session covers the following topics on protein and peptide drug discovery:

• Anti-depressants drug class
• Anti-psychotics drug class
• anti-psychotics
• epilepsy drugs
• Alzheimer' s disease drugs
• migraine drugs
• ADHD drugs((Attention Deficit Hyperactivity Disorder)
• Parkinson' s disease drugs
• Anti-Schizophrenia Drugs
• As selected other CNS drugs

  Or you can propose new topics to be covered from your expert opinion here!

Session 14: Proteins/Peptides For Cardiovascular & Cerebrovascular Disease

Speaking Opportunities Available

This session covers the following topics on protein and peptide drug discovery:

• Coronary heart disease
• Cerebrovascular disease
• Peripheral arterial disease
• Rheumatic heart disease
• Congenital heart disease
• Deep vein thrombosis and pulmonary embolism

  Or you can propose new topics to be covered from your expert opinion here!

Session 15: Nanomaterials, Peptide / Protein Drug Delivery Technology

Speaking Opportunities Available

This session covers the following topics on protein and peptide drug delivery technology development::

• Oral Deliverable Segment
• Inhalation System
• Polymer Development
• Protein Drug Delivery Technologies
• Developments in Polyethylene Glycol (PEG)
• Vaccines and Mono-clone antibody DDS
• Nanotech
• Buccal Development
• Drug Delivery to the Eye

  Or you can propose new topics to be covered from your expert opinion here!